
What happened
In fiscal 2026, Aehr posted $50.0 million revenue (down 15.2%), a $7.1 million net loss, and negative $5.4 million free cash flow, while KLA reported $13.6 billion revenue (up 11.7%), $4.8 billion net income, and $3.8 billion free cash flow.
Why it matters
KLA's profitability and dividend make it the more stable option for AI exposure, whereas Aehr's losses and cash burn signal higher risk for investors.
What to watch
Aehr's high stock valuation suggests future growth is already priced in, limiting upside, and its customer concentration remains a key risk. Watch whether Aehr's record bookings of $60.7 million convert into profitable revenue.
WHO IT HITSThis comparison directly informs retail investors and portfolio managers deciding how to allocate AI exposure, particularly those weighing small-cap growth against mega-cap stability in semiconductor equipment.
Summaries like this, every morning.
The comparison comes as investors look for ways to gain exposure to artificial intelligence beyond the headline chipmakers. Aehr Test Systems serves the high-growth silicon carbide market for electric vehicles and high-bandwidth memory for AI infrastructure, but its fiscal 2026 results show the risks of that niche: revenue fell 15.2% to $50.0 million, and the company swung to a $7.1 million net loss. Its five largest customers accounted for nearly 70% of net sales, exposing it to the capital spending cycles of a handful of buyers.
KLA, by contrast, provides process control tools across the entire chip-making industry. Its scale showed in fiscal 2026, with revenue up 11.7% to $13.6 billion and net income of $4.8 billion. Its services business, about 23% of revenue, adds a recurring stream. KLA is not without concentration risk, as Taiwan Semiconductor Manufacturing Company accounts for more than 10% of revenues, and it faces competition from Applied Materials and Lasertec.
The valuation gap is stark: Aehr trades at a much higher multiple despite its net loss, while KLA's forward P/E is 33.1x. The Motley Fool's pick hinges on whether Aehr's record bookings of $60.7 million and fourth-quarter sales of $18.8 million can translate into sustained profitability, or whether KLA's steady profit and dividend will continue to look safer for AI exposure.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
Anthropic applied to list on Nasdaq under "ANT," but its amended Nov

UBS estimates about 30% of the data-center capacity the U.S

Alignable's Eric Groves writes that Meta brought its Muse agent to small businesses in September, while Anthro…

Ramp's November card data shows U.S

Anthropic filed its public S-1 registration statement with the SEC on October 26, planning to list on Nasdaq u…

The Commerce Department approved New Matrix, created 17 months ago, to handle Nvidia's H200 AI chips, but The…
